Image Trademark with Serial Number 98907246
Status: 630 - New Application - Record Initialized Not Assigned To Examiner
Image for trademark with serial number 98907246
Serial Number
98907246
Status
630 - New Application - Record Initialized Not Assigned To Examiner
Status Date
2024-12-17
Filing Date
2024-12-17
Attorney Name
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Description of Mark
The mark consists of a blood drop.
Goods and Services
Compiling data for research purposes in the field of medical science and medical consultancy; Medical and scientific research in the field of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, and immunology related to biomarker discovery and validation, drug discovery and development, diagnostics development, and translational applications; Providing an on-line searchable database in the field of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, immunology and health for scientific research purposes; Providing an on-line searchable database in the field of biospecimen and data collection for scientific research purposes; Providing information about medical research in the field of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, and immunology for purposes including biomarker discovery and validation, drug discovery and development, diagnostics development, and other translational applications; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Research laboratory analysis services in the field of biospecimens for cell analysis assays, cell count, immunophenotyping, and HLA typing for use in infectious disease research; Research laboratory analysis services in the field of providing biospecimen analysis, cell analysis assays, cell count, immunophenotyping, and HLA typing for use in infectious disease research; Scientific laboratory services; Scientific research for medical purposes in the field of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, immunology, biomarker discovery and validation, drug discovery and development, diagnostics development, and translational applications; Scientific research in the field of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, oncology and health research; Providing scientific research information in the field of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, immunology, biomarker discovery and validation, drug discovery and development, diagnostics development, and translational applications via biospecimen collection and data collection; Providing scientific research information in the field of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, immunology, biomarker discovery and validation, drug discovery and development, diagnostics development, and translational applications via biospecimen collection and data collection for research purposes
Classification Information
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2024-12-17
Primary Code
042
First Use Anywhere Date
2023-05-18
First Use In Commerce Date
2023-05-18
Current Trademark Owners
Party Type
10 - Original Applicant
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Elizabeth Oliner Oliner Law
Address
Please log in with your Justia account to see this address.
Trademark Events
Event DateEvent Description
2024-12-17NEW APPLICATION ENTERED